Robert Downey Jr. Threatening To Quit Avengers As Deadpool Rumors Heat Up

As a cinephile eagerly anticipating the next blockbuster, I can’t help but share some intriguing whispers that have made the rounds recently. It seems the initial script for an upcoming production might have faced some changes in its course. Word on the street is that the masterminds behind the sensational Deadpool are now taking up their quills to rework it. Fascinating, isn’t it? Stay tuned for further updates!

Ambarella’s AI Gamble Sparks Wall Street Frenzy

Folks, Ambarella’s revenue swelled to $95.5 million this quarter-nigh on 50% higher than last year. Now, I ain’t no mathematician, but that’s enough to make a banker’s mustache quiver. Profits? They inched up 16% to $6.4 million, or $0.15 per share if you’re countin’ pennies. Analysts? Bless their hearts, they expected less-like underestimatin’ a hungry rattlesnake in a chicken coop.

The Retail Leviathan: Why Amazon Always Wins

But here’s the thing: Harold wasn’t entirely wrong about one thing-investing in companies with momentum can work. It’s just that instead of gambling on memes, you might want to look at something slightly more substantial. Like Amazon. Yes, *that* Amazon. The company so ubiquitous it feels like it’s already taken over your life-and possibly your checking account.

Caterpillar’s Tariff Tango: A $1.8B Waltz with the Devil

Thursday’s regulatory filing, a document as thick with foreboding as a Stalinist edict, revealed Caterpillar’s grim calculus: a $1.5 billion to $1.8 billion tariff-induced wound for the year. This, they admitted, was a revision-upward, as if the devil himself had sharpened his quill. The original $1.5 billion forecast, once a mere scratch on the ledger of fate, now seemed a prelude to a far darker ledger. For the third quarter alone, the toll would be $500 million to $600 million, a sum that might as well have been scribbled by a bureaucrat drunk on absinthe.

Will Hyperliquid (HYPE) Bounce Back or Crash? The $42 Mystery Deepens 🤔💸

Oh, the drama! Hyperliquid just had one of its most dramatic falls since its last tea party. In just 48 hours, it plummeted from a lofty $50.91 to a humble $43.75-a drop of $7.16, according to the ever-watchful Henrik. It’s almost as if the market said, “Oops, we got carried away!” and decided to yank the rug out from under everyone’s feet. Technically speaking, this breakdown suggests that supply has gobbled up demand like a greedy ogre at a buffet. 🐲🍴

BBAI: A Dip or a Bottomless Pit?

Nestled in a Virginia suburb that smells faintly of bureaucracy and coffee, BigBear.ai is the kind of company that would have been hired by the Ministry of Magic to automate the sorting of owls. Its mission? To provide mission-ready AI solutions to defense agencies, a task that sounds both urgent and slightly absurd when you consider how many humans it employs to explain what “mission-ready” actually means.

The Unraveling of Curaleaf: A Dance of Stock and Stigma

The grand, tantalizing notion of federal marijuana rescheduling has long hovered like a half-open door in the shadowy corridors of American policy. President Donald Trump, that veritable magus of the unexpected, has mused about moving marijuana from the most dangerous tier of the DEA’s drug classifications-a symbolic shift that would, in theory, herald the end of prohibition in the land of the free. Popular? Yes, almost universally so, if we trust the vox populi. But a select coterie of legislators, adorned in the cloaks of their partisan convictions, seeks to turn back this promise of progress. They wish to rewrite the script, to keep the status quo-their own intransigence shackled to the past.